Iovance Biotherapeutics, Inc. (LON:0JDK)

Iovance Biotherapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 27, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	837	1,802	1,633	837	2,212	4,985
Market Cap Growth	-52.69%	10.29%	95.14%	-62.16%	-55.63%	89.02%
Enterprise Value	656	1,547	1,412	605	1,840	4,470
Last Close Price	2.09	5.80	6.40	5.12	14.31	32.95
PS Ratio	4.49	13.75	1749.89	-	-	-
PB Ratio	1.60	3.18	3.56	2.02	4.82	10.37
P/TBV Ratio	2.70	5.27	5.86	2.02	4.82	10.37
EV/Sales Ratio	3.59	11.81	1512.80	-	-	-
Debt / Equity Ratio	0.08	0.08	0.13	0.17	0.12	0.08
Asset Turnover	0.26	0.19	0.00	-	-	-
Inventory Turnover	4.40	4.01	-	-	-	-
Quick Ratio	2.92	3.21	2.54	5.16	5.66	11.47
Current Ratio	3.41	3.74	2.79	5.24	5.70	11.59
Return on Equity (ROE)	-53.89%	-57.48%	-81.91%	-70.61%	-53.55%	-54.34%
Return on Assets (ROA)	-27.12%	-29.22%	-39.86%	-34.59%	-27.71%	-29.42%
Return on Capital Employed (ROCE)	-52.80%	-50.20%	-68.70%	-69.70%	-49.80%	-36.70%
Earnings Yield	-35.33%	-16.50%	-21.34%	-39.25%	-11.43%	-3.81%
FCF Yield	-31.26%	-16.14%	-18.46%	-31.05%	-8.87%	-3.70%
Buyback Yield / Dilution	-19.46%	-23.28%	-47.64%	-3.82%	-10.92%	-11.23%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.